Navigation Links
Wiley Prize in Biomedical Sciences awarded to Rosbash, Hall and Young
Date:1/31/2013

The 12th annual Wiley Prize in Biomedical Sciences has been awarded to Brandeis professors Michael Rosbash and Jeffrey Hall and their colleague Michael Young of Rockefeller University for the discovery of the molecular mechanisms governing circadian rhythms.

"The molecular network discovered by these researchers imparts cyclic behavior to many biological processes including sleep and wakefulness, metabolism and even the response to drugs," said Professor Gnter Blobel, chairman of the awards jury for the Wiley Prize and a 1999 Nobel Prize winner.

Their research could ultimately lead to the development of drugs to treat sleep disorders, physical and mental illness, and even jet lag.

Five previous Wiley Prize winners have gone on to win the Nobel Prize in either physiology or medicine.

Rosbash and Hall spent more than three decades at Brandeis collaboratively researching circadian rhythms, the biological clock which governs functions such as sleep and wakefulness, metabolism and hormone levels in organisms as simple as fruit flies and as complex as humans.

"We were incredibly fortunate to have advanced this problem in the remarkable way things have turned out," says Rosbash. "Jeff and I, as well as Mike Young at Rockefeller, began these studies in the fruit fly with no certainty in my case, no expectation that the fly clockworks would be essentially identical in humans. So our work not only turned out to be interesting but also potentially important. How lucky can three guys get?"

Their research uses the fruit fly Drosophila, a model organism valued for almost a century because of its relative genetic simplicity and its wide range of behaviors. At the molecular level, circadian rhythms use the same genes and are regulated in much the same way in all animals, including humans. Rosbash and Hall cloned the first Drosophila circadian clock gene in 1984.

"The discoveries they made in terms of identifying the first circadian clock genes is really a landmark in understanding how genes regulate behavior, and understanding our own 24-hour rhythms that seem to regulate so much of our biology," says Ravi Allada, professor and chair of the Department of Neurobiology at Northwestern University, who worked in the Rosbash Lab from 1995 to 2000.

Amita Sehgal, the John Herr Musser Professor of Neuroscience at the University of Pennsylvania and an investigator with the Howard Hughes Medical Institute, said the trio's groundbreaking research "opened up the whole field of circadian rhythms and inspired people like me to go into it."

"I'm really glad that they're getting recognized for it. It's a tremendous honor for them, but also for the field," said Sehgal, who worked as a post-doc in Young's lab at Rockefeller.

The Wiley Prize in Biomedical Sciences has recognized work that opens new fields of research or advanced novel concepts or their applications in a particular biomedical discipline.

This year's award will be presented to Rosbash, Hall and Dr. Young on April 5 at Rockefeller University in New York City.


'/>"/>

Contact: Susan Chaityn Lebovits
lebovits@brandies.edu
781-736-4027
Brandeis University
Source:Eurekalert  

Related biology news :

1. Physiological societies partner with Wiley on new open access journal
2. Wiley Partners with TED
3. British Ecological Society partners with Wiley open access journal Ecology and Evolution
4. Wiley signs collaboration agreement with the Asian Federation of Biotechnology
5. Wiley launches new interdisciplinary review WIREs Energy and Environment
6. Wiley-Blackwell launches new open-access journal: Food Science & Nutrition
7. WileyChina.com - Now Featuring Bespoke Pages for China’s Life Scientists
8. Israel Prize awarded to Tel Aviv University biochemist
9. Brupbacher Prize goes to cancer researcher Michael Karin
10. 2 climate scientists win 2012 Vetlesen Prize for work on ozone hole, ice cores
11. Leibniz Prizes 2013: DFG honors 11 outstanding researchers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Wiley Prize in Biomedical Sciences awarded to Rosbash, Hall and Young
(Date:3/22/2016)... 22, 2016 According ... Market for Consumer Industry by Type (Image, Motion, ... (Communication & IT, Entertainment, Home Appliances, & ... to 2022", published by MarketsandMarkets, the market ... reach USD 26.76 Billion by 2022, at ...
(Date:3/17/2016)... -- ABI Research, the leader in transformative technology ... will reach more than $30 billion by 2021, ... electronics, particularly smartphones, continue to boost the biometrics ... two billion shipments by 2021 at a 40% ... Analyst at ABI Research. "Surveillance is also gearing ...
(Date:3/14/2016)... http://www.apimages.com ) - ... - Renvoi : image disponible via AP Images ( ... --> DERMALOG, le leader de l,innovation ... d,empreintes digitales pour l,enregistrement des réfugiés en Allemagne. ... produire des cartes d,identité aux réfugiés. DERMALOG dévoilera ...
Breaking Biology News(10 mins):
(Date:5/20/2016)... ... May 20, 2016 , ... The leading Regenerative Veterinary Medicine ... experienced veterinary clients have treated over 100 of their own patients with the VetStem ... the highest level of care for their patients. , The veterinarians are Dr ...
(Date:5/20/2016)... ... ... The recent recall by Costco and Trader Joes of 47 million pounds ... 2016(1), demonstrates the need for faster and more cost effective bio-threat detection to ensure ... , PathSensor’s latest solution uses a biosensor technology called CANARY®. CANARY®, ...
(Date:5/19/2016)... May 19, 2016 There is ... recover given the relentless pressures in pricing and lack ... the investors circle though - numerous opportunities are up ... today,s session, ActiveWallSt.com,s presents four names in this sector: ... Pharmaceuticals Inc. (NASDAQ: VTAE ), Anthera Pharmaceuticals ...
(Date:5/19/2016)... - I dati saranno presentati ... 52 ° Congresso della Società ... - Le conclusioni dello studio indicano un tasso di ... cui il 90% presenta una d urata della risposta ... settantadue per cento dei pazienti ha riscontrato un beneficio clinico. ...
Breaking Biology Technology: